Adocia and Tonghua Dongbao Announce Global Supply Agreements for Insulin Lispro and Insulin Glargine

Press Release, June 1st 2018: Adocia and Tonghua Dongbao Announce Global Supply Agreements for Insulin Lispro and Insulin Glargine.

Tonghua Dongbao will manufacture and supply insulin glargine and insulin lispro to Adocia worldwide, excluding China.

Adocia Press Release June 1st, 2018

These agreements expand the previously announced strategic alliance between both companies whereby Tonghua Dongbao had received licenses to develop and commercialize Adocia’s BioChaperone® Lispro and BioChaperone® Combo in China and other territories

Adocia Press Release April 26th, 2018